There has been significant research into the potential of Immunoglobulin Y (IgY) as a solution to address some of today’s largest infectious and non-communicable disease challenges ranging from pandemic preparedness to the realities of antibiotic resistance.
This research has also helped to validate the ability for IgY Technology to address a broad spectrum of immune health issues in both human and animal health. We are currently in market with Consumer Health products and in development of several Biologic Drugs and Animal Health solutions.